Laboratory Testing for Subconjunctival Hemorrhage and Bleeding Gums
For a patient presenting with both subconjunctival hemorrhage and bleeding gums, order a complete blood count (CBC), prothrombin time (PT)/INR, and activated partial thromboplastin time (aPTT) as initial hemostasis tests to investigate for thrombocytopenia or coagulopathy. 1
Rationale for Testing Approach
The combination of subconjunctival hemorrhage with bleeding gums represents mucocutaneous bleeding at multiple sites, which warrants hemostatic evaluation. While isolated subconjunctival hemorrhage is typically benign and self-limiting 1, the presence of concurrent gingival bleeding elevates concern for an underlying bleeding disorder.
Initial Laboratory Panel
The Canadian Cardiovascular Society guidelines specifically recommend that patients developing ecchymosis and petechiae (similar mucocutaneous bleeding patterns) should undergo:
- Complete blood count - to detect thrombocytopenia
- INR - to assess extrinsic coagulation pathway
- aPTT - to evaluate intrinsic coagulation pathway 1, 2
This initial testing can identify coagulation factor deficiencies or platelet count abnormalities that may be causing the bleeding 3.
When to Proceed with Additional Testing
If initial tests are normal but bleeding history is convincing, consider von Willebrand disease (VWD) testing, as this is the most common inherited bleeding disorder and can present with normal screening tests 3, 4. The NHLBI guidelines recommend three VWD-specific tests 3:
- VWF antigen (VWF:Ag)
- VWF activity (VWF:GPIbM or VWF:GPIbR preferred over older VWF:RCo assay)
- Factor VIII coagulant activity
Important Clinical Context
Medication review is critical - particularly for antiplatelet agents (aspirin, clopidogrel) or anticoagulants (warfarin), as these are common causes of minor bleeding 1. If the patient is on antiplatelet therapy, the guidelines state that in the absence of abnormal hemostatic function tests, these medications can typically be continued with clinical observation 1.
Common Pitfalls to Avoid
Don't dismiss isolated subconjunctival hemorrhage with concurrent bleeding elsewhere - While research shows isolated SCH doesn't require bleeding disorder workup 5, the presence of gingival bleeding changes the clinical picture to suggest possible systemic hemostatic dysfunction.
Don't rely on PT/aPTT alone - Normal PT and aPTT do not exclude platelet disorders or VWD, which are the most common bleeding disorders 4.
Consider age and context - In elderly patients, vascular fragility from hypertension is more common 6, while in younger patients without trauma history, inherited bleeding disorders warrant stronger consideration.
When Hemostasis Tests Are Normal
If CBC, PT/INR, and aPTT are normal but clinical suspicion remains high based on bleeding severity or recurrence, refer to hematology for specialized testing including VWD panel and potentially platelet function testing 3, 4. The presence of thrombocytopenia or coagulopathy on initial testing mandates stopping any antiplatelet agents pending further investigation 1.